Your browser doesn't support javascript.
loading
Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease.
Stricker, R B; Goldberg, B; Epstein, W L.
Affiliation
  • Stricker RB; Department of Medicine, California Pacific Medical Center, San Francisco 94108, USA. rstricker@barron-centers.com
Immunol Lett ; 59(3): 145-50, 1997 Dec.
Article in En | MEDLINE | ID: mdl-9419021
ABSTRACT
In this article, we present the concept of topical immune modulation, or TIM. TIM is based on the observation that skin contact sensitizing agents such as poison ivy, poison oak and dinitrochlorobenzene (DNCB) are potent stimulants of the cellular immune system that combats viruses and other pathogens. We discuss the evolution of DNCB as a therapeutic modality in the acquired immunodeficiency syndrome (AIDS) and we explore the mechanism by which DNCB directs the immune response. The potential use of topical immune modulators in autoimmune disease and vaccine development is also delineated. TIM represents a novel approach to immunotherapy that should have widespread application for immunologic diseases.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Acquired Immunodeficiency Syndrome / Anti-HIV Agents / Dinitrochlorobenzene Language: En Journal: Immunol Lett Year: 1997 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Acquired Immunodeficiency Syndrome / Anti-HIV Agents / Dinitrochlorobenzene Language: En Journal: Immunol Lett Year: 1997 Type: Article Affiliation country: United States